Skip to content

Low FODMAPs diet in patients with IBS-D

Low FODMAPs diet vs. general dietary advice improves clinical response in patients with IBS-D: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017093033308N1
Enrollment
110
Registered
2017-10-09
Start date
2017-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome with diarrhoea

Interventions

Intervention 1: Low FODMAP diet. Intervention 2: general dietary advices.
Treatment - Other
Low FODMAP diet

Sponsors

Vice Chancellor for research; Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: . Inclusion criteria for participants' enrollment were IBS with diarrhea subtype (Bristol Stool Form Scale = 5) and age 20-60 years old. Exclusion criteria were having a confounder medical condition such as celiac disease, inflammatory bowel disease (IBD) or presence of cardiovascular, liver, kidney, neurologic diseases, diabetes and thyroid disorders, consumption of ?-3 FAs and other nutritional supplements in the last 3 months, pregnancy in during the study. The use of effective drugs against IBS such as drugs affecting GI motility was not allowed, but antidepressants drugs were allowed on a stable dose for the last 3 months before inclusion.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gastrointestinal symptoms. Timepoint: 3 weeks. Method of measurement: questionnaire.;Bowel habit status. Timepoint: 6 weeks. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: 6 weeks. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahideh Behrouz

Kerman University of Medical Sciences

vahideh.behrouz@gmail.com+98 34 3251 0380

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026